Financial Snapshot

Revenue
$34.75M
TTM
Gross Margin
71.41%
TTM
Net Earnings
-$24.76M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
232.95%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
-$63.81M
Q3 2024
Cash
Q3 2024
P/E
-0.9009
Nov 29, 2024 EST
Free Cash Flow
-$39.33M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020
Revenue $53.47M $0.00 $0.00 $0.00
YoY Change

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020
Revenue $53.47M $0.00 $0.00 $0.00
Cost Of Revenue $11.97M $13.49M $9.050M
Gross Profit $41.50M $50.73M $29.19M
Gross Profit Margin 77.61%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020
Selling, General & Admin $92.68M $4.688M $2.231M $5.170K
YoY Change 1877.12% 110.09% 43058.8%
% of Gross Profit 223.34% 9.24% 7.64%
Research & Development $27.52M $16.88M $5.550M
YoY Change 63.0% 204.14%
% of Gross Profit 66.31% 33.27% 19.01%
Depreciation & Amortization $746.0K $900.0K $710.0K
YoY Change -17.11% 26.76%
% of Gross Profit 1.8% 1.77% 2.43%
Operating Expenses $120.6M $4.688M $2.231M $5.170K
YoY Change 2472.17% 110.09% 43058.8%
Operating Profit -$79.08M $46.04M $26.96M
YoY Change -271.75% 70.79%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020
Interest Expense $20.91M $37.15M $7.887M
YoY Change -43.72% 370.99%
% of Operating Profit 80.68% 29.26%
Other Income/Expense, Net -$643.0K $2.077M $144.1K
YoY Change -130.95% 1341.88%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020
Pretax Income -$80.34M $34.54M $5.763M -$5.170K
YoY Change -332.63% 499.31% -111563.25%
Income Tax $264.0K $2.165M $0.00
% Of Pretax Income 6.27% 0.0%
Net Earnings -$82.30M $32.37M $5.763M -$5.170K
YoY Change -354.25% 461.74% -111563.25%
Net Earnings / Revenue -153.93%
Basic Earnings Per Share -$2.31 -$1.51
Diluted Earnings Per Share -$2.31 $0.32 $0.06 $0.00

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020
Cash & Short-Term Investments $38.04M $765.8K $836.9K $47.09K
YoY Change 4867.09% -8.49% 1677.17%
Cash & Equivalents $38.04M $765.8K $836.9K
Short-Term Investments
Other Short-Term Assets $2.414M $71.51K $774.7K
YoY Change 3275.75% -90.77%
Inventory $6.171M $3.870M $2.720M
Prepaid Expenses
Receivables $18.19M $29.35M $6.830M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $64.82M $1.012M $1.612M $47.09K
YoY Change 6303.41% -37.19% 3322.28%
Property, Plant & Equipment $6.391M $5.280M $1.710M
YoY Change 21.04% 208.77%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $94.33M $862.5M
YoY Change -89.06%
Other Assets $505.0K $2.710M $0.00 $282.9K
YoY Change -81.37% -100.0%
Total Long-Term Assets $6.896M $94.33M $862.5M $282.9K
YoY Change -92.69% -89.06% 304817.2%
Total Assets $71.71M $95.34M $864.2M $330.0K
YoY Change
Accounts Payable $10.38M $4.190K $8.050K $117.9K
YoY Change 247608.83% -47.95% -93.17%
Accrued Expenses $13.57M $40.00K $363.0K $22.22K
YoY Change 33822.5% -88.98% 1533.48%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $932.0K $0.00 $170.0K
YoY Change -100.0% -100.0%
Long-Term Debt Due $38.64M $53.36M $24.14M
YoY Change -27.58% 121.04%
Total Short-Term Liabilities $65.43M $1.376M $371.0K $310.1K
YoY Change 4654.03% 270.93% 19.63%
Long-Term Debt $0.00 $0.00 $1.393M $0.00
YoY Change -100.0%
Other Long-Term Liabilities $76.77M $7.830M $61.41M
YoY Change 880.56% -87.25%
Total Long-Term Liabilities $76.77M $7.830M $62.81M $0.00
YoY Change 880.56% -87.53%
Total Liabilities $142.2M $9.206M $63.18M $310.1K
YoY Change 1444.67% -85.43% 20271.26%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020
Basic Shares Outstanding 35.58M 26.92M
Diluted Shares Outstanding 35.58M 26.92M
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $22.306 Million

About ALLURION TECHNOLOGIES, INC.

Allurion Technologies, Inc. develops treatments for obesity. The company is headquartered in Natick, Massachusetts and currently employs 249 full-time employees. The company went IPO on 2021-03-29. The firm offers Allurion Virtual Care Suite, including the Allurion Mobile App for consumers, Allurion Insights for health care providers featuring the Iris AI Platform and health tracker devices. Its health tracker devices include Allurion Connected Scale and Allurion Health Tracker. Allurion Connected Scale offers a complete weight tracking experience, allowing users to monitor their weight, body mass index (BMI) and body composition. Allurion Health Tracker tracks steps, exercise and sleep. Allurion Virtual Care Suite is available to providers separately from the Allurion Program to help customize, monitor and manage weight-loss therapy for patients regardless of their treatment plan, which includes gastric balloon, surgical and medical or nutritional. Its Allurion Programme is offered in six months, 12 months and 12-18 months program.

Industry: Surgical & Medical Instruments & Apparatus Peers: Beachbody Company, Inc. CARRIAGE SERVICES INC Wag! Group Co. European Wax Center, Inc. XWELL, Inc. REGIS CORP WW INTERNATIONAL, INC.